A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer

Clinical trial NCT04621370 · UNKNOWN

Trial details

NCT number: NCT04621370
Sponsor: Liz-Anne Lewsley
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Rectal Cancer Rectal Adenocarcinoma Rectal Neoplasms

Start date: 2020-12-07
Primary completion: 2025-06-30
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.